A CT scan showing an adenocarcinoma of the pancreatic head.
January 23, 2013 A study of a new drug therapy for pancreatic cancer finds it works better than the standard approach. While the improvement is modest for the typical patient, some people who received the treatment lived a year or two longer than those receiving conventional therapy.
NPR thanks our sponsors
Become an NPR sponsor